How can small firms benefit from open innovation? : the case of new drug development in Taiwan
Year of publication: |
2016
|
---|---|
Authors: | Su, Yu-Shan ; Hu, Hsin-Yi ; Wu, Feng-Shang |
Published in: |
International journal of technology management : IJTM. - Geneva-Aeroport : Inderscience Enterprises Ltd, ISSN 0267-5730, ZDB-ID 55978-7. - Vol. 72.2016, 1/3, p. 61-82
|
Subject: | open innovation | small firms | external partners | new drug development | Taiwan | biotechnology firms | KMU | SME | Open Innovation | Open innovation | Pharmakologie | Pharmacology | Biotechnologie-Industrie | Biotechnology industry | Innovation | Pharmaindustrie | Pharmaceutical industry | Produktentwicklung | New product development | Innovationsmanagement | Innovation management |
-
Open innovation : a real option to restore value to the biopharmaceutical R&D
Lo Nigro, Giovanna, (2014)
-
Inbound open innovation in biopharmaceutical firms : unpacking the role of absorptive capacity
Russo Spena, Tiziana, (2019)
-
Mazzola, Erica, (2015)
- More ...
-
Regional systems of biotechnology innovation : the case of Taiwan
Su, Yu-Shan, (2015)
-
Impacts of misbehaving air passengers on frontline employees: role stress and emotional labor
Hu, Hsin-Hui“Sunny”, (2017)
-
Impacts of misbehaving air passengers on frontline employees : role stress and emotional labor
Hu, Hsin-Hui, (2017)
- More ...